In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

C4X Discovery Holdings plc

https://www.c4xdiscovery.com/

Latest From C4X Discovery Holdings plc

After World-Leading Vaccine Roll-Out, UK Eyes Booster Phase But Faces Pressure To Help Globe

The UK’s purchase of 60 million extra Pfizer/BioNTech COVID vaccine doses, plus bets on Novavax and Valneva and others gives it a buffer against new variants – so when will it pledge to donate to more needy nations?

Coronavirus COVID-19 Vaccines

After World-Leading COVID-19 Vaccine Roll-Out, UK Looks To Next Phase

The UK’s purchase of 60 million extra Pfizer/BioNTech doses, plus bets on Novavax and Valneva and others gives it a buffer against new variants – so when will it pledge to donate to more needy nations?

Commercial Companies

Sanofi Partnership On Oral IL-17 Could Be Turning Point For C4XD

The UK drug discovery specialist has made slow progress until now, but the Sanofi deal could yield a challenger in the competitive psoriasis field.

Commercial Companies

Deal Watch: Gain To Test Enzyme-Enhancement Tech In Cancer With Zentalis

Argenx partners with Elektrofi and Iontas; China’s Qilu obtains global rights to Peptron’s antibody-drug conjugate and also ends co-development pact with Quantum Genomics.

Deals Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • C4X Discovery Limited
UsernamePublicRestriction

Register